MyMemory, World's Largest Translation Memory
Click to expand

Language pair: Click to swap content  Subject   
Ask Google

You searched for: portatore cronico di hbsag    [ Turn off colors ]

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Italian

English

Info

Portatore sano

Asymptomatic carrier

Last Update: 2013-10-11
Usage Frequency: 1
Quality:
Reference: Wikipedia

Portatore sano

Genetic carrier

Last Update: 2013-11-18
Usage Frequency: 1
Quality:
Reference: Wikipedia

Stato di portatore
http://aims.fao.org/standards/agrovoc

carrier state
http://aims.fao.org/standards/agrovoc

Last Update: 2013-06-12
Subject: Agriculture and Farming
Usage Frequency: 1
Quality:
Reference: fao.org

Sero-conversione HBsAg

HBsAg Sero-conversion

Last Update: 2008-03-04
Subject: Medical
Usage Frequency: 8
Quality:
Reference: Euromed
Warning: This alignment may be wrong.
Please delete it you feel so.

Stato di portatore asintomatico
http://aims.fao.org/standards/agrovoc

asymptomatic carrier state
http://aims.fao.org/standards/agrovoc

Last Update: 2013-06-12
Subject: Agriculture and Farming
Usage Frequency: 1
Quality:
Reference: fao.org

Ospite portatore / Vettore

Reservoir/host

Last Update: 2012-12-01
Usage Frequency: 1
Quality:
Reference:

Perdita HBsAg / sieroconversione
http://www.emea.europa.eu/

HBsAg loss/ seroconversion
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: europa.eu

Infine, i documenti citati dal richiedente indicano che UMAN BIG è riuscito ad evitare che i neonati di madri infette da HBeAg diventassero portatori cronici dell' HBsAg.
http://www.emea.europa.eu/

Finally, the papers quoted by the Applicant indicate that UMAN BIG prevented newborns from HBeAg infected mothers from becoming chronic HBsAg carriers.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: europa.eu

In genere i portatori cronici restano capaci di trasmettere l'infezione per tutta la vita.
http://www.ecdc.europa.eu/e [...] ges/home.aspx

Chronic carriers usually remain infectious throughout their life.
http://www.ecdc.europa.eu/e [...] ges/home.aspx

Last Update: 2014-06-03
Subject: Medical
Usage Frequency: 1
Quality:
Reference: europa.eu
Warning: This alignment may be wrong.
Please delete it you feel so.

I pazienti con epatopatia cronica o con infezione da HIV o portatori di epatite C non devono essere esclusi dalla vaccinazione contro epatite B.
http://www.emea.europa.eu/

Patients with chronic liver disease or with HIV infection or hepatitis C carriers should not be precluded from vaccination against hepatitis B.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: europa.eu

La vaccinazione contro l’ epatite B non deve essere esclusa in pazienti affetti da malattie croniche del fegato o con infezione da HIV o portatori di epatite C.
http://www.emea.europa.eu/

Patients with chronic liver disease or with HIV infection or hepatitis C carriers should not be precluded from vaccination against hepatitis B.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 8
Quality:
Reference: europa.eu

Una persona può portare i batteri nell'intestino per periodi di tempo molto lunghi (portatori cronici) e trasmetterli ad altre persone (direttamente o attraverso contaminazione di cibo o acqua).
http://www.ecdc.europa.eu/e [...] ges/home.aspx

Humans can carry the bacteria in the gut for very long times (chronic carriers), and transmit the bacteria to other persons (either directly or via food or water contamination).
http://www.ecdc.europa.eu/e [...] ges/home.aspx

Last Update: 2014-06-03
Subject: Medical
Usage Frequency: 1
Quality:
Reference: europa.eu
Warning: This alignment may be wrong.
Please delete it you feel so.

In pazienti portatori cronici del virus dell’ epatite B sottoposti a trattamento con antagonisti del TNF Me
http://www.emea.europa.eu/

Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Trudexa, who are chronic carriers of this virus.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: europa.eu

In pazienti portatori cronici del virus dell’ epatite B sottoposti a trattamento con antagonisti del TNF incluso TRUDEXA, si è verificata una riattivazione dell’ epatite B.
http://www.emea.europa.eu/

Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Trudexa, who are chronic carriers of this virus.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 4
Quality:
Reference: europa.eu

Cronica
http://www.emea.europa.eu/

Chronic
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: europa.eu

Riattivazione di epatite B La riattivazione dell’ epatite B si è osservata in pazienti trattati con un TNF-antagonista, incluso il Remicade e che erano portatori cronici di questo virus.
http://www.emea.europa.eu/

7 Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Remicade, who are chronic carriers of this virus.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: europa.eu

In particolare, i portatori cronici asintomatici devono essere identificati e trattati prima della vaccinazione con sostanze che non compromettano la risposta immunitaria.
http://www.emea.europa.eu/

In particular, chronic asymptomatic carriers should be identified and treated before vaccination, with substances that do not compromise immunological responsiveness.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 3
Quality:
Reference: europa.eu

nei pazienti con epatite cronica B (CHB) HBeAg positiva, il trattamento deve essere somministrato per almeno 3-6 mesi dopo che la sieroconversione HBeAg (scomparsa di HBeAg e HBV DNA con rilevazione di HBeAb) è stata confermata, per limitare il rischio di ricaduta virologica o fino alla sieroconversione HBsAg.
http://www.emea.europa.eu/

In patients with HBeAg positive chronic hepatitis B (CHB) treatment should be administered for at least 3-6 months after HBeAg seroconversion (HBeAg and HBV DNA loss with HBeAb detection) is confirmed, to limit the risk of virological relapse, or until HBsAg seroconversion.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: europa.eu

35 In pazienti portatori cronici del virus dell’ epatite B quando sottoposti a trattamento con antagonisti del TNF incluso Humira, si è verificata una riattivazione dell’ epatite B.
http://www.emea.europa.eu/

Reactivation of hepatitis B has occurred in patients who are chronic carriers of this virus when receiving a TNF-antagonist including Humira.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: europa.eu

E’ stata riportata riattivazione del virus dell’ Epatite B (HBV) in pazienti portatori cronici di questo virus che ricevono anti-TNF come Enbrel.
http://www.emea.europa.eu/

Reactivation of hepatitis B virus (HBV) in patients who are chronic carriers of this virus who are receiving TNF-antagonists including Enbrel has been reported.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:
Reference: europa.eu

Add a translation